An adenovirus-mediated gene-transfer model of angiogenesis in rat mesentery

Microcirculation

Volumn 11, Issue 4, 2004, Pages 361-375

  Wang, Wen Ying ^a   Whittles, Cheryl E ^a   Harper, Steven J ^a   Bates, David O ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adenovirus; Angiogenesis; Mesentery; Proliferation; Sprouting; VEGF; VEGFR2

Indexed keywords

ACTIN; ADENOVIRUS VECTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE TRANSFER; IMAGING SYSTEM; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; MALE; MESENTERY BLOOD VESSEL; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS EXPRESSION;

ADENOVIRIDAE; ANIMALS; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; MALE; MICROSCOPY, VIDEO; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; SPLANCHNIC CIRCULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

ADENOVIRIDAE; ANIMALIA; RATTUS NORVEGICUS;

EID: 7444224577     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1080/10739680490437568     Document Type: Article

References (49)

1. Bates DO. (1998). The chronic effect of vascular endothelial growth factor on individually perfused frog mesenteric microvessels. J Physiol (Lond) 513:225-233.
2. Bates DO, Curry FE. (1996). Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am J Physiol 271:H2520-H2528.
3. Bates DO, Harper SJ. (2002). Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 39:225-237.
4. Bates DO, Heald RI, Curry FE, Williams B. (2001). Vascular endothelial growth factor increases Rana vascular permeability and compliance by different signalling pathways. J Physiol 533:263-272.
5. Chang DS, Su H, Tang GL, Brevetti LS. Sarkar R, Wang R, Kan YW, Messina LM. (2003). Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb. Mol Ther 7:44-51.
6. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. (1992). The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
7. Egginton S, Zhou AL, Brown MD, Hudlicka O. (2001). Unorthodox angiogenesis in skeletal muscle. Cardiovasc Res 49:634-646.
8. Enholm B, Karpanen T, Jeltsch M,. Kubo H, Stenback F, Prevo R, Jackson DG, Yla-Herttuala S, Alitalo K. (2001). Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res. 88:623-629.
9. Feng D, Nagy JA, Brekken RA, Pettersson N, Manseau EJ, Pyne K, Mulligan R, Thorpe PE, Dvorak HF, Dvorak AM. (2000). Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 48:545-556.
10. Fishkind DJ, Wang YL. (1993). Orientation and three-dimensional organization of actin filaments in dividing cultured cells. J Cell Biol 123:837-848.
11. Fong TA, Shawver LK, Sun L, Tang C, App H, Powell TJ, Kim YH, Schreck R, Wang X, Risau W, Ullrich A, Hirth KP, McMahon G. (1999). SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res 59:99-106
12. Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, Pelletier N, Ferrara N. (2001). Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2): a reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 276:3222-3230.
13. Helisch A, Schaper W. (2003). Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10:83-97.
14. Heuser LS, Taylor SH, Folkman J. (1984). Prevention of carcinomatosis and bloody malignant ascites in the rat by an inhibitor of angiogenesis. J Surg Res 36:244-250.
15. Hiltunen MO, Ruuskanen M, Huuskouen J, Mahonen AJ, Ahonen M, Rutanen J, Kosma VM, Mahonen A, Kroger H, Yla-Herttuala S. (2003). Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. Faseb J 8:8.
16. Hudlicka O. (1984). Development of the microcirculation:capillary growth and adaptation. In: Handbook of Physiology: The Cardiovascular System: Microcirculation. Sect 2, Vol IV, Part 1, Chapt. 5 (CC Michel and EM Renkin, Eds.) Bethesda, MD: American Physiological Society, 165-216.
17. Huxley VH, Curry FE. (1991). Differential actions of albumin and plasma on capillary solute permeability. Am J Physiol H1645-H1654.
18. Malavaud B, Tack I, Jonca F, Praddaude F, Moro F, Ader JL, Plouet J. (1997). Activation of Flk-1/KDR mediates angiogenesis but not hypotension. Cardiovasc Res 36:276-281.
19. Michel CC, Mason JC, Curry FE, Tooke JE, Hunter PJ. (1974). A development of the Landis technique for measuring the filtration coefficient of individual capillaries in the frog mesentery. Qu J Exp Physiol Cognitive Med Sci 59:283-309.
20. Muhlhauser J, Merrill MJ, Pili R, Maeda Bacic M, Bewig B, Passaniti A, Edwards NA, Crystal RG, Capogrossi MC. (1995). VFGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ Res 77:1077-1086.
21. Mukhopadhyay D, Nagy JA, Manseau EJ, Dvorak HF. (1998). Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium. Cancer Res 58:1278-1284.
22. Nagamatsu S, Nakamichi Y, Ohara-Imaizumi M, Ozawa S, Katahira H, Watanabe T, Ishida H. (2001). Adenovirus-mediated preproinsulin gene transfer into adipose tissues ameliorates hyperglycemia in obese diabetic KKA(y) mice. FEBS Lett 509:106-110.
23. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ, Dvorak AM, Dvorak HF. (2002). Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196:1497-1506.
24. Nehls V, Denzer K, Drenckhahn D. (1992). Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 270:469-474.
25. Norrby K. (1996). Vascular endothelial growth factor and de novo mammalian angiogenesis. Microvasc Res 51:153-163.
26. Norrby K, Bani D, Bigazzi M, Banni Sacchi T. (1996). Relaxin, a potent microcirculatory, effector, is not angiogenic. Int J Microcirc Clin Exp 16:227-231.
27. Norrby K, Jakobsson A, Sorbo J. (1986). Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch B Cell Pathol Incl Vol Pathol 52:195-206.
28. 2+]i with sites of macromolecular leakage. Microcirculation 1:213-230.
29. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, Dvorak AM, Mulligan RC, Dvorak HF. (2000). Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 80:99-115.
30. Pocock TM, Bates DO. (2001). In vivo mechanisms of vascular endothelial growth factor-mediated increased hydraulic conductivity of Rana capillaries. J Physiol 534:479-488.
31. Price RJ, Skalak TC. (1998). Prazosin administration enhances proliferation of arteriolar adventitial fibroblasts. Microvasc Res 55:138-145.
32. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT. (1993). Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90:7533-7537.
33. Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H, Betsholtz C, Shima DT. (2002). Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 16:2684-2698.
34. Schafer DA, Welch MD, Machesky LM, Bridgman PC, Meyer SM, Cooper JA. (1998). Visualization and molecular analysis of actin assembly in living cells. J Cell Biol 143:1919-1930.
35. Schaper W, Scholz D. (2003). Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 3:3.
36. Smaje LH, Fraser PA, Clough G. (1980). The distensibility of single capillaries and venules in the cat mesentery. Microvasc Res 20:358-370.
37. Sorbo J, Jakobsson A, Norrby K. (1994). Mast-cell histamine is angiogenic through receptors for histamine 1 and histamine2. Int J Exp Pathol 75:43-50.
38. Springer ML, Ozawa CR, Banfi A, Kraft PE, Ip TK, Brazelton TR, Blau HM. (2003). Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. Mol Ther 7:441-449.
39. Sundberg C, Nagy JA, Brown LF, Feng D, Eckelhoefer IA, Manseau EJ, Dvorak AM, Dvorak HF. (2001). Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol 158:1145-1160.
40. Thurston G, Murphy, TJ, Baluk P, Lindsey JR, McDonald DM. (1998). Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am J Pathol 153:1099-1112.
41. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. (1999). Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511-2514.
42. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP. (1996). Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103:1820-1828.
43. Van Gieson EJ, Murfee WL, Skalak TC, Price RJ. (2003). Enhanced smooth muscle cell coverage of microvessels exposed to increased hemodynamic stresses in vivo. Circ Res 92:929-936.
44. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. (1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988-26995.
45. Whittles CE, Pocock TM, Harper SJ, Bates D. (2001). ZM323881, an inhibitor of vascular endothelial growth factor receptors, attenuates VEGF-induced increases in hydraulic conductivity (Lp) in frog mesenteric microvessels in vivo. J Vasc Res 38:409.
46. Wilting J, Christ B, Bokeloh M, Weich HA. (1993). In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res 274:163-172.
47. Wright MJ, Wightman LM, Latchman DS, Marber MS. (2001). In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo. Gene Ther 8:1833-1839.
48. Wu HM, Huang Q, Yuan Y, Granger HJ. (1996). VEGF induces NO-dependent hyperpemeability in coronary venules. Am J Physiol Heart Circ Physiol 271:H2735-H2739.
49. Zhang HT, Scott PA, Morbidelli L, Peak S, Moore J, Turley H, Harris AL, Ziche M, Bicknell R. (2000). The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer 83:63-68.